AU691221B2 - Type 1 and type P fimbriae-adhesins isolated from novel E coli strains, process for their preparation and uses thereof - Google Patents
Type 1 and type P fimbriae-adhesins isolated from novel E coli strains, process for their preparation and uses thereofInfo
- Publication number
- AU691221B2 AU691221B2 AU11503/95A AU1150395A AU691221B2 AU 691221 B2 AU691221 B2 AU 691221B2 AU 11503/95 A AU11503/95 A AU 11503/95A AU 1150395 A AU1150395 A AU 1150395A AU 691221 B2 AU691221 B2 AU 691221B2
- Authority
- AU
- Australia
- Prior art keywords
- type
- fimbriae
- adhesins
- coli strains
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 241000588724 Escherichia coli Species 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 239000012506 Sephacryl® Substances 0.000 abstract 1
- 229920002684 Sepharose Polymers 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 238000005119 centrifugation Methods 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000013049 sediment Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Paints Or Removers (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9400202 | 1994-02-04 | ||
| ES09400202A ES2076895B1 (es) | 1994-02-04 | 1994-02-04 | Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1150395A AU1150395A (en) | 1995-08-17 |
| AU691221B2 true AU691221B2 (en) | 1998-05-14 |
Family
ID=8285106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU11503/95A Ceased AU691221B2 (en) | 1994-02-04 | 1995-02-01 | Type 1 and type P fimbriae-adhesins isolated from novel E coli strains, process for their preparation and uses thereof |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0666271B1 (de) |
| JP (1) | JP2851556B2 (de) |
| AT (1) | ATE185814T1 (de) |
| AU (1) | AU691221B2 (de) |
| BR (1) | BR9500546A (de) |
| CA (1) | CA2141475C (de) |
| DE (1) | DE69512808T2 (de) |
| DK (1) | DK0666271T3 (de) |
| ES (1) | ES2076895B1 (de) |
| GR (1) | GR3032332T3 (de) |
| PT (1) | PT666271E (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004512817A (ja) * | 2000-03-10 | 2004-04-30 | アンスティテュ ナショナル ド ラ サンテ エ ド ラ ルシェルシュ メディカル （イ．エヌ．エス．エ．エール．エム．） | 大腸菌から単離される、ｂ２／ｄ＋ａ−型のポリヌクレオチド、ならびにこれらのポリヌクレオチドとそのポリペプチドの生物学的使用 |
| EP1342784A1 (de) * | 2002-03-06 | 2003-09-10 | Mutabilis S.A. | ExPEC-spezifische Proteine, entsprechende Gene und ihre Verwendungen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ205392A (en) * | 1982-09-02 | 1987-03-06 | Unilever Plc | Preparation of immunoglobulins against e.coli pili |
| DK41885A (da) * | 1985-01-31 | 1986-11-13 | Slagteriernes Forskningsinst | 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen |
| US4725435A (en) * | 1986-06-18 | 1988-02-16 | Bactex, Inc. | Vaccine composition for immunization against urinary tract infection caused by E. coli |
| WO1990000614A1 (en) * | 1988-07-13 | 1990-01-25 | Baylor College Of Medicine | Receptor specific proteins and their use in receptor typing |
| DE3832785A1 (de) * | 1988-09-27 | 1990-04-19 | Max Planck Gesellschaft | Verfahren zur gewinnung von p-adhaesin |
-
1994
- 1994-02-04 ES ES09400202A patent/ES2076895B1/es not_active Expired - Fee Related
-
1995
- 1995-01-31 CA CA002141475A patent/CA2141475C/en not_active Expired - Fee Related
- 1995-02-01 AU AU11503/95A patent/AU691221B2/en not_active Ceased
- 1995-02-02 AT AT95200257T patent/ATE185814T1/de not_active IP Right Cessation
- 1995-02-02 PT PT95200257T patent/PT666271E/pt unknown
- 1995-02-02 DE DE69512808T patent/DE69512808T2/de not_active Expired - Fee Related
- 1995-02-02 DK DK95200257T patent/DK0666271T3/da active
- 1995-02-02 EP EP95200257A patent/EP0666271B1/de not_active Expired - Lifetime
- 1995-02-03 JP JP7016819A patent/JP2851556B2/ja not_active Expired - Fee Related
- 1995-02-06 BR BR9500546A patent/BR9500546A/pt not_active Application Discontinuation
-
2000
- 2000-01-12 GR GR20000400030T patent/GR3032332T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0666271T3 (da) | 2000-04-17 |
| EP0666271A1 (de) | 1995-08-09 |
| CA2141475C (en) | 1999-08-24 |
| JPH0834798A (ja) | 1996-02-06 |
| GR3032332T3 (en) | 2000-04-27 |
| ES2076895A1 (es) | 1995-11-01 |
| JP2851556B2 (ja) | 1999-01-27 |
| ES2076895B1 (es) | 1996-08-16 |
| ATE185814T1 (de) | 1999-11-15 |
| EP0666271B1 (de) | 1999-10-20 |
| CA2141475A1 (en) | 1995-08-05 |
| PT666271E (pt) | 2000-04-28 |
| DE69512808D1 (de) | 1999-11-25 |
| DE69512808T2 (de) | 2000-06-15 |
| BR9500546A (pt) | 1997-05-27 |
| AU1150395A (en) | 1995-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL142691A (en) | Use of an antibody which binds to ailim protein in the manufacture of medicament for preventing, treating or prophylaxis of graft versus host reaction | |
| US20090004242A1 (en) | Coatings and Biomedical Implants Formed From Keratin Biomaterials | |
| NZ511956A (en) | Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies | |
| KR910004209A (ko) | 에스케리키아 콜리 왁진 | |
| EP0326149B1 (de) | Adjuvanz für Krebsimmuntherapie | |
| AU691221B2 (en) | Type 1 and type P fimbriae-adhesins isolated from novel E coli strains, process for their preparation and uses thereof | |
| GB2261666A (en) | Multivalent anti-cytokine immunoglobulins | |
| EP1366082B1 (de) | Hochsulfatierte derivate von k5-polysacchariden und ihre herstellung | |
| AU2002236118A1 (en) | Highly sulfated derivatives of K5 polysaccharide and their preparation | |
| PL316935A1 (en) | Heparin bonding protein for treating septicaemia and method of obtaining such protein | |
| DK0918464T3 (da) | Fremgangsmåde til fremstilling af kolostralmælkeprodukter samt deres anvendelse | |
| AU2003285286A1 (en) | Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol) | |
| Diao et al. | Optimisation of the clarification of kiwifruit juice with tannic acid-modified chitosan. | |
| AU631674B2 (en) | Pokeweed antiviral protein - monoclonal antibody conjugates | |
| JPH0770209A (ja) | 多糖物質ｎｐｓ、その製造法および用途 | |
| US7241735B2 (en) | Pharmacologically active polypeptide glycoconjugates | |
| DE69724328T2 (de) | Konjugate von einem Interleukin-2 Rezeptor spezifisch erkennenden Faktor mit Ribonuklease | |
| JPH0265790A (ja) | 免疫賦活作用を有する粗糖蛋白質画分及びその製造法 | |
| Armes et al. | The complete primary structure of pilin from Haemophilus influenzae type b strain Eagan | |
| JPS6153221A (ja) | 新規多糖体ｒｉｎ物質，その製造法およびそれを有効成分とする抗腫瘍剤，免疫調節剤並びに感染症予防治療剤 | |
| KR960013393B1 (ko) | 재조합 효모에서 발현된 알파 인터페론의 정제방법 | |
| IL70731A0 (en) | New preparation process for immunostimulating acylglycoproteins extracted from klebsiella pneumoniae,anti-allergic pharmaceutical compositions and method of treatment of allergic diseases | |
| KR100772007B1 (ko) | 마크로파지 활성화 또는 항암용 알로에 조성물 | |
| 佐々木康人 et al. | Effect of Non-dialyzable Extract of Amaranth Seeds on Immunoglobulin Production and Proliferation of a Human-human Hybridoma Cell Line, HFlOB4. | |
| RU2078573C1 (ru) | Способ выделения с5-компонента комплемента человека |